212P Real-world progression-free survival 2 with CDK4/6 inhibitors plus endocrine therapy and subsequent line: Results from the multicenter SISTER study
Title:
212P Real-world progression-free survival 2 with CDK4/6 inhibitors plus endocrine therapy and subsequent line: Results from the multicenter SISTER study
Author:
Morganti, S. Gandini, S. Nicolo, E. Zattarin, E. Corti, C. Verrazzo, A. Giachetti, P.P.M. Berton Sposetti, C. Razeti, M.G. Salimbeni, B. Taurelli Boldrini, L. Schianca, A. Carnevale Caputo, R. Vernieri, C. Munzone, E. Lambertini, M. De Laurentiis, M. Viale, G. Curigliano, G. Criscitiello, C.